Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 246

    1.

    Male sex increases the risk of autoimmunity but not type 1 diabetes.

    Krischer JP, Cuthbertson DD, Greenbaum C; Diabetes Prevention Trial-Type 1 Study Group.

    Diabetes Care. 2004 Aug;27(8):1985-90.PMID: 15277428 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes.

    Williams AJ, Bingley PJ, Moore WP, Gale EA; ENDIT Screening Group. European Nicotinamide Diabetes Intervention Trial.

    Diabetologia. 2002 Feb;45(2):217-23.PMID: 11935153 [PubMed - indexed for MEDLINE]Related articles

    3.

    Screening strategies for the identification of multiple antibody-positive relatives of individuals with type 1 diabetes.

    Krischer JP, Cuthbertson DD, Yu L, Orban T, Maclaren N, Jackson R, Winter WE, Schatz DA, Palmer JP, Eisenbarth GS.

    J Clin Endocrinol Metab. 2003 Jan;88(1):103-8.PMID: 12519837 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial.

    Füchtenbusch M, Rabl W, Grassl B, Bachmann W, Standl E, Ziegler AG.

    Diabetologia. 1998 May;41(5):536-41.PMID: 9628270 [PubMed - indexed for MEDLINE]Related articles

    5.

    The presence of thyrogastric antibodies in first degree relatives of type 1 diabetic patients is associated with age and proband antibody status.

    De Block CE, De Leeuw IH, Decochez K, Winnock F, Van Autreve J, Van Campenhout CM, Martin M, Gorus FK; Belgian Diabetes Registry.

    J Clin Endocrinol Metab. 2001 Sep;86(9):4358-63.PMID: 11549675 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1.

    Yu L, Cuthbertson DD, Maclaren N, Jackson R, Palmer JP, Orban T, Eisenbarth GS, Krischer JP; DPT-1 Participating Investigators.

    Diabetes. 2001 Aug;50(8):1735-40.PMID: 11473032 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk.

    Bingley PJ, Gale EA; European Nicotinamide Diabetes Intervention Trial (ENDIT) Group.

    Diabetologia. 2006 May;49(5):881-90. Epub 2006 Mar 3.PMID: 16514546 [PubMed - indexed for MEDLINE]Related articles

    9.

    Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases.

    Lindholm E, Hallengren B, Agardh CD.

    Diabetes Metab Res Rev. 2004 Mar-Apr;20(2):158-64.PMID: 15037992 [PubMed - indexed for MEDLINE]Related articles

    10.

    Islet cell antibody-positive relatives with human leukocyte antigen DQA1*0102, DQB1*0602: identification by the Diabetes Prevention Trial-type 1.

    Greenbaum CJ, Schatz DA, Cuthbertson D, Zeidler A, Eisenbarth GS, Krischer JP.

    J Clin Endocrinol Metab. 2000 Mar;85(3):1255-60.PMID: 10720072 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes.

    Decochez K, Truyen I, van der Auwera B, Weets I, Vandemeulebroucke E, de Leeuw IH, Keymeulen B, Mathieu C, Rottiers R, Pipeleers DG, Gorus FK; Belgian Diabetes Registry.

    Diabetologia. 2005 Apr;48(4):687-94. Epub 2005 Mar 9.PMID: 15756536 [PubMed - indexed for MEDLINE]Related articles

    12.

    Autoantibodies and human leucocyte antigen class II in first-degree family members of Mexican-American type 1 diabetic patients.

    Zeidler A, Raffel LJ, Costin G, Shaw SJ, Buchanan TA, Noble J, Rotter JI, Palmer J, Krischer JP, Wait C, Maclaren NK.

    J Clin Endocrinol Metab. 2001 Oct;86(10):4957-62.PMID: 11600569 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Combination of autoantibody markers and risk for development of type 1 diabetes: results from a large french cohort of family members.

    Thivolet C, Nicolino M, Monbeig S, Estour B, Halimi S, Robert M, Orgiazzi J, Chatelain P; GRADI study.

    Diabetes Metab. 2002 Sep;28(4 Pt 1):279-85.PMID: 12442065 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Increased prevalence of thyroid autoantibodies and subclinical thyroid failure in relatives of patients with overt endocrine disease-associated diabetes but not type 1 diabetes alone.

    Maugendre D, Massart C, Karacatsanis C, Guilhem I, Poirier JY, Sonnet E, Allannic H.

    Diabetes Metab. 1997 Sep;23(4):302-7.PMID: 9342543 [PubMed - indexed for MEDLINE]Related articles

    15.

    The high prevalence of autoantibodies to tissue transglutaminase in first-degree relatives of patients with type 1 diabetes is not associated with islet autoimmunity.

    Williams AJ, Norcross AJ, Lock RJ, Unsworth DJ, Gale EA, Bingley PJ.

    Diabetes Care. 2001 Mar;24(3):504-9.PMID: 11289476 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Islet cell antibodies and beta-cell function in gestational diabetic women: comparison to first-degree relatives of type 1 (insulin-dependent) diabetic subjects.

    Mauricio D, Corcoy R, Codina M, Morales J, Balsells M, de Leiva A.

    Diabet Med. 1995 Nov;12(11):1009-14.PMID: 8582122 [PubMed - indexed for MEDLINE]Related articles

    18.

    Elimination of dietary gluten does not reduce titers of type 1 diabetes-associated autoantibodies in high-risk subjects.

    Hummel M, Bonifacio E, Naserke HE, Ziegler AG.

    Diabetes Care. 2002 Jul;25(7):1111-6.PMID: 12087006 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.
    20.

    Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials.

    Bingley PJ, Williams AJ, Gale EA.

    Diabetes Care. 1999 Nov;22(11):1796-801.PMID: 10546010 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data